CC
Cheryl Cohen (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in ImmunityBio, Inc. (IBRX). The largest single filing was $1.2M of IBRX (131,210 sh × $9.50, as filed), executed Jul 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.1M
shares × price, as filed
Last traded
Oct 2
Filed Oct 6
Median ADV $90.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
IBRX
ImmunityBio, Inc.
IBRX · 0 buys · 2 sells
2 filings
Recent filings
IBRXSALE
ImmunityBio, Inc.
View filing →
$851K81,056 sh × $10.50
Exec Oct 2
Filed Oct 6 · 6:05 PM ET IBRXSALE ImmunityBio, Inc. View filing → $1.2M
131,210 sh × $9.50
Exec Jul 2
Filed Jul 6 · 8:26 PM ET